Recently, a large-scale exon resequencing of two exons of MTNR1B has examined 40 rare mutants and demonstrated impairment in melatonin binding and signalling, establishing a functional link between this receptor and T2D risk [91]. The gene discussed is MTNR1B; the disease is type 2 diabetes mellitus.